# Novartis Pharmaceuticals Corporation, Vacaville, CA – FDA Inspections

Source: https://www.keypedia.com/companies/novartis-pharmaceuticals-corporation/326f95cc-f2ac-4a21-8b19-5c99bd8ef53c

> Inspection records and compliance data for Novartis Pharmaceuticals Corporation in Vacaville, California. 7 FDA inspections on record, last inspected November 02, 2012.

---

## Details

- Name: Novartis Pharmaceuticals Corporation
- FEI Number: 3000215618
- Address Line 1: 2010 Cessna Dr
- City: Vacaville
- State: California
- Zip Code: 95688
- Country Name: United States
- Address: 2010 Cessna Dr, Vacaville, California 95688, United States
- Country: United States

## Related Documents

- [CRL - Novartis Pharmaceuticals Corporation - Unknown Date](https://www.keypedia.com/records/crl/novartis-pharmaceuticals-corporation/87c4b2b3-0fe3-4b0f-843c-a8258a82fe75) — source: FDA, date: Invalid Date
- FDA Inspection 821628 - Novartis Pharmaceuticals Corporation - 2012-11-02 — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 2, 2012
- FDA Inspection 735205 - Novartis Pharmaceuticals Corporation - 2011-07-18 — classification: No Action Indicated (NAI), source: FDA, date: July 18, 2011
- FDA Inspection 725203 - Novartis Pharmaceuticals Corporation - 2011-05-12 — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 12, 2011
- FDA Inspection 678015 - Novartis Pharmaceuticals Corporation - 2010-08-27 — classification: No Action Indicated (NAI), source: FDA, date: August 27, 2010
- FDA Inspection 637079 - Novartis Pharmaceuticals Corporation - 2009-12-10 — classification: No Action Indicated (NAI), source: FDA, date: December 10, 2009
- FDA Inspection 589805 - Novartis Pharmaceuticals Corporation - 2009-05-13 — classification: No Action Indicated (NAI), source: FDA, date: May 13, 2009
- [FDA Inspection 562113 - Novartis Pharmaceuticals Corporation - 2009-02-05](https://www.keypedia.com/records/fda_inspections/novartis-pharmaceuticals-corporation/fbc3b680-4a0d-4b56-840d-4ccf86a24559) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 5, 2009

## Related Companies

- [St. Jude Children's Research Hospital](https://www.keypedia.com/companies/st-jude-childrens-research-hospital/821a4e4c-3929-4e0f-8d44-7b2217d1889f)
- [Corey G. Anderson, M.D.](https://www.keypedia.com/companies/corey-g-anderson-md/a4e1398f-d75f-4df2-a4a1-567d96132e60)
- [Santa Clara Valley Medical Center IRB](https://www.keypedia.com/companies/santa-clara-valley-medical-center-irb/0550f2bb-e176-4532-b6b7-433b14e7a0b8)
- [Sinikka L. Green, M.D.](https://www.keypedia.com/companies/sinikka-l-green-md/6f6aff2d-c4d7-4828-ac6a-0df5a95ed73d)
- [Experimental Pathology Laboratories, Inc.](https://www.keypedia.com/companies/experimental-pathology-laboratories-inc/07560578-c354-4567-87aa-954ea009a40b)
- [Charles River Laboratories Inc.](https://www.keypedia.com/companies/charles-river-laboratories-inc/3d0a09d7-c46e-4e4e-b6d4-2b55e331c427)
- [Charles River Laboratories Montreal ULC](https://www.keypedia.com/companies/charles-river-laboratories-montreal-ulc/68187cd6-70a7-481c-9d23-28d63a9bfd6b)
- [Columbia University Medical Center IRB](https://www.keypedia.com/companies/columbia-university-medical-center-irb/cce93871-8b9d-4226-83df-f11ea120e828)
- [Ardea Biosciences, Inc.](https://www.keypedia.com/companies/ardea-biosciences-inc/b9477ee7-61c5-46dc-80c1-9cfd4e2d1c1e)
- [Peter J. Winkle M.D.](https://www.keypedia.com/companies/peter-j-winkle-md/59f4c9fd-ab2a-4f72-9d4a-95d9ab6ab35f)

## Related Officers

- [Andrew Friedman, PharmD](https://www.keypedia.com/people/andrew-friedman-pharmd/1b90de17-aaea-4b37-b900-f10fab46a1c9)